RARA and acute promyelocytic leukemia: These specific PLZF interactions, with subsequent transcriptional dysregulation and differentiation block, are responsible for the different disease phenotypes (chronic myeloid leukemia-like in mice models vs. classic APL phenotype in PML::RARA models) and the resistance to ATRA and ATO [104].